Algert Global LLC Vanda Pharmaceuticals Inc. Transaction History

Algert Global LLC

  • $3.72 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 15, 2022
BUY
$9.44 - $11.76 $111,675 - $139,120
11,830 New
11,830 $117,000
Q1 2019

May 01, 2019
SELL
$17.59 - $31.05 $1.34 Million - $2.37 Million
-76,204 Closed
0 $0
Q4 2018

Feb 01, 2019
BUY
$18.97 - $31.47 $1.45 Million - $2.4 Million
76,204 New
76,204 $1.99 Million

Others Institutions Holding VNDA

# of Institutions
157
Shares Held
44.9M
Call Options Held
165K
Put Options Held
33.6K
View Full List

About Vanda Pharmaceuticals Inc.

VNDA Quotes by TradingView
  • Ticker VNDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,561,500
  • Market Cap $249M
  • Description
  • Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...
More about VNDA
Track This Portfolio

Track Algert Global LLC Portfolio

Follow Algert Global LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

News

Stay updated on Algert Global LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email